Author:
Ricchi Paolo,Cinque Patrizia,Lanza Galeota Alfonso,Di Matola Tiziana,Ammirabile Massimiliano,Prossomariti Luciano
Publisher
Springer Science and Business Media LLC
Reference15 articles.
1. Yeo W, Johnson PJ. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology. 2006;43:209–20. doi:
10.1002/hep.21051
.
2. Wonke B, Wright C, Hoffbrand AV. Combined therapy with deferiprone and desferrioxamine. Br J Haematol. 1998;103:361–644. doi:
10.1046/j.1365-2141.1998.01002.x
.
3. Origa R, Bina P, Agus A, Crobu G, Defraia E, Dessì C, et al. Combined therapy with deferiprone and desfoerrioxamine in thalassemia major. Haematologica. 2005;90:1163–8.
4. Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ. Comparison of effects of oral deferiprone and subsutaneous desferrioxamine on myocardial iron concentrations and ventricular function in β-thalassaemia. Lancet. 2002;360:516–20. doi:
10.1016/S0140-6736(02)09740-4
.
5. Piga A, Gaglioti C, Fogliacco E, Tricta F. Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis. Haematologica. 2003;88:489–96.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献